[Prevention of vertical transmission and treatment of infection caused by the human immunodeficiency virus in the pregnant woman. Recommendations of the Study Group for AIDS, Infectious Diseases, and Clinical Microbiology, the Spanish Pediatric Association, the National AIDS Plan and the Spanish Gynecology and Obstetrics Society]

MeSH terms

• AIDS Serodiagnosis
• Abnormalities, Drug-Induced / etiology
• Acidosis, Lactic / chemically induced
• Acidosis, Lactic / epidemiology
• Adult
• Animals
• Anti-HIV Agents / administration & dosage
• Anti-HIV Agents / adverse effects
• Anti-HIV Agents / therapeutic use
• Antiretroviral Therapy, Highly Active
• Breast Feeding / adverse effects
• Cesarean Section
• Clinical Trials as Topic
• Delivery, Obstetric
• Drug Resistance, Viral
• Drug Therapy, Combination
• Family Health
• Female
• Fetal Diseases / etiology
• Fetal Diseases / virology
• HIV Infections / drug therapy
• HIV Infections / epidemiology
• HIV Infections / prevention & control*
• HIV Infections / transmission
• HIV Protease Inhibitors / administration & dosage
• HIV Protease Inhibitors / adverse effects
• HIV Protease Inhibitors / therapeutic use
• HIV Reverse Transcriptase / antagonists & inhibitors
• Humans
• Infant, Newborn
• Infectious Disease Transmission, Vertical / prevention & control*
• Informed Consent
• Male
• Maternal-Fetal Exchange
• Neoplasms, Experimental / chemically induced
• Preconception Care
• Pregnancy
• Pregnancy Complications, Infectious / drug therapy*
• Pregnancy Complications, Infectious / epidemiology
• Prenatal Care
• Rats
• Reproductive Techniques
• Reverse Transcriptase Inhibitors / administration & dosage
• Reverse Transcriptase Inhibitors / adverse effects
• Reverse Transcriptase Inhibitors / therapeutic use
• Spain / epidemiology
• Viral Load